Jingjing Han1,2, Yan Geng1,2, Xuerong Deng1,2, Zhuoli Zhang3,4. 1. From the Department of Geriatrics, and the Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China. 2. J. Han, MD, Department of Geriatrics, Peking University First Hospital; Y. Geng, MD, Department of Rheumatology and Clinical Immunology, Peking University First Hospital; X. Deng, MD, Department of Rheumatology and Clinical Immunology, Peking University First Hospital; Z. Zhang, MD, PhD, Department of Rheumatology and Clinical Immunology, Peking University First Hospital. 3. From the Department of Geriatrics, and the Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China. zhuoli.zhang@126.com. 4. J. Han, MD, Department of Geriatrics, Peking University First Hospital; Y. Geng, MD, Department of Rheumatology and Clinical Immunology, Peking University First Hospital; X. Deng, MD, Department of Rheumatology and Clinical Immunology, Peking University First Hospital; Z. Zhang, MD, PhD, Department of Rheumatology and Clinical Immunology, Peking University First Hospital. zhuoli.zhang@126.com.
Abstract
OBJECTIVE: Subclinical synovitis can be detected by ultrasound in patients with rheumatoid arthritis (RA) who are in clinical remission. We aimed to confirm its predictive value for flare and progressive bone erosion. METHODS: A systematic literature search was performed in Pubmed, Web of Science, Embase, and Cochrane Library on September 7, 2014. Baseline clinical and ultrasonographic characteristics were collected. Methodological quality was assessed. Pooled OR were calculated using Mantel-Haenszel model. We explored the source of heterogeneity through subgroup analysis and completed a cumulative metaanalysis. RESULTS: Thirteen articles were included (8 with flare, 4 with bone erosion, 1 with both flare and bone erosion). Metaanalysis revealed an association between power Doppler (PD) positivity and the risk of flare (OR 4.52, 95% CI 2.61-7.84, p < 0.00001, I2 = 21%), the risk of progressive bone erosion on patient level (OR 12.80, 95% CI 1.29-126.81, p = 0.03, I2 = 52%) and the risk of progressive bone erosion on joint level (OR 11.85, 95% CI 5.01-28.03, p < 0.00001, I2 = 0%). Further subgroup analysis showed a higher risk of flare in patients with a study period < 1 year (OR 19.98 vs 3.41). No significant differences were observed in the subgroup analysis in duration of remission, disease duration, and medications. Moreover, cumulative metaanalysis indicated the validation and an increasing accuracy of PD positivity in predicting flare since 2012. CONCLUSION: Ultrasound-detected subclinical synovitis can predict the risk of flare and progressive bone erosion in RA patients with clinical remission. Additionally, the flare of RA tends to occur within a followup of 1 year.
OBJECTIVE: Subclinical synovitis can be detected by ultrasound in patients with rheumatoid arthritis (RA) who are in clinical remission. We aimed to confirm its predictive value for flare and progressive bone erosion. METHODS: A systematic literature search was performed in Pubmed, Web of Science, Embase, and Cochrane Library on September 7, 2014. Baseline clinical and ultrasonographic characteristics were collected. Methodological quality was assessed. Pooled OR were calculated using Mantel-Haenszel model. We explored the source of heterogeneity through subgroup analysis and completed a cumulative metaanalysis. RESULTS: Thirteen articles were included (8 with flare, 4 with bone erosion, 1 with both flare and bone erosion). Metaanalysis revealed an association between power Doppler (PD) positivity and the risk of flare (OR 4.52, 95% CI 2.61-7.84, p < 0.00001, I2 = 21%), the risk of progressive bone erosion on patient level (OR 12.80, 95% CI 1.29-126.81, p = 0.03, I2 = 52%) and the risk of progressive bone erosion on joint level (OR 11.85, 95% CI 5.01-28.03, p < 0.00001, I2 = 0%). Further subgroup analysis showed a higher risk of flare in patients with a study period < 1 year (OR 19.98 vs 3.41). No significant differences were observed in the subgroup analysis in duration of remission, disease duration, and medications. Moreover, cumulative metaanalysis indicated the validation and an increasing accuracy of PD positivity in predicting flare since 2012. CONCLUSION: Ultrasound-detected subclinical synovitis can predict the risk of flare and progressive bone erosion in RApatients with clinical remission. Additionally, the flare of RA tends to occur within a followup of 1 year.
Authors: Dana E Orange; Phaedra Agius; Edward F DiCarlo; Serene Z Mirza; Tania Pannellini; Jackie Szymonifka; Caroline S Jiang; Mark P Figgie; Mayu O Frank; William H Robinson; Laura T Donlin; Cristina Rozo; Ellen M Gravallese; Vivian P Bykerk; Susan M Goodman Journal: Arthritis Rheumatol Date: 2019-06-05 Impact factor: 10.995
Authors: Emilio Filippucci; Edoardo Cipolletta; Riccardo Mashadi Mirza; Marina Carotti; Andrea Giovagnoni; Fausto Salaffi; Marika Tardella; Andrea Di Matteo; Marco Di Carlo Journal: Radiol Med Date: 2019-03-09 Impact factor: 3.469
Authors: Juan José de Agustín; Alba Erra; Andrés Ponce; Carmen Moragues; Cesar Díaz-Torné; Delia Reina; Estefanía Moreno; Julio Ramírez; Lourdes Mateo; Manel Pujol Busquets; Patricia Moya; Pilar Santo-Panero; Sergi Ros-Expósito; Javier Narváez; Raimon Sanmartí; Mª Jesús García de Yébenes; Loreto Carmona Journal: Rheumatol Int Date: 2019-08-08 Impact factor: 2.631
Authors: Katie Bechman; Lieke Tweehuysen; Toby Garrood; David L Scott; Andrew P Cope; James B Galloway; Margaret H Y Ma Journal: J Rheumatol Date: 2018-09-01 Impact factor: 4.666
Authors: Isabel Morales-Ivorra; Javier Narváez; Carmen Gómez-Vaquero; Carmen Moragues; Joan M Nolla; José A Narváez; Manuel Alejandro Marín-López Journal: RMD Open Date: 2022-07
Authors: Daniel Kuo; Nicolette T Morris; Gurjit S Kaeley; Ami Ben-Artzi; Jenny Brook; David A Elashoff; Veena K Ranganath Journal: Clin Rheumatol Date: 2020-08-15 Impact factor: 2.980